Latest Schedule 13G passive stakes
NYSE
MAGN
Magnera CORPMorgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a decrease in their beneficial ownership of Magnera Corp's common stock to below the 5% threshold.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Capital Services LLC, have filed an amendment to their Schedule 13G, reporting a decrease in their beneficial ownership of Magnera Corp's common stock to below the 5% threshold.
NYSE
SCHEDULE: TFI International Stakeholder Update
Several entities associated with Scotiabank have adjusted their beneficial ownership stake in TFI International Inc., now collectively holding 3.079% of the company's common shares.
NASDAQ
CXAI
Cxapp INCJane Street Group, LLC and its affiliates have reported a beneficial ownership stake of 5.3% in CXApp Inc. common stock as of June 30, 2026.
NYSE
Morgan Stanley and its subsidiary have reported a decrease in their beneficial ownership of Cohen & Steers Select Preferred & Income Fund, Inc. common stock to below the 5% threshold.
NYSE
Morgan Stanley and its subsidiary have reported a decrease in their beneficial ownership of Cohen & Steers Select Preferred & Income Fund, Inc. common stock to below the 5% threshold.
NYSE
Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.4% of Mountain Crest Acquisition 6's ordinary shares.
NASDAQ
Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 6.4% of Mountain Crest Acquisition 6's ordinary shares.
NYSE
CAE
Cae INCA Schedule 13G filing reveals that 1832 Asset Management L.P., MD Financial Management Inc., and Scotia Capital Inc. collectively hold a 6.4% stake in CAE Inc. as of June 30, 2026.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 7.2% of GalaxyEdge Acquisition Corporation's ordinary shares as of June 30, 2026.
NYSE
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported beneficial ownership of 7.2% of GalaxyEdge Acquisition Corporation's ordinary shares as of June 30, 2026.
NYSE
Morgan Stanley entities have reported a decrease in their beneficial ownership of C4 Therapeutics, Inc. common stock, now holding less than 5% collectively.
NASDAQ
Morgan Stanley entities have reported a decrease in their beneficial ownership of C4 Therapeutics, Inc. common stock, now holding less than 5% collectively.
NYSE
Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.1% of Newbridge Acquisition Limited's Class A Ordinary Shares as of June 30, 2026.
NASDAQ
Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, reporting beneficial ownership of 7.1% of Newbridge Acquisition Limited's Class A Ordinary Shares as of June 30, 2026.
NASDAQ
Jane Street Group, LLC and its affiliates have reported beneficial ownership of 20,125,585 shares, representing 6.3% of Core Scientific, Inc.'s common stock.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an updated Schedule 13G, reporting a combined beneficial ownership of 14.1% in BlackRock 2037 Municipal Target Term Trust.
NYSE
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an updated Schedule 13G, reporting a combined beneficial ownership of 14.1% in BlackRock 2037 Municipal Target Term Trust.
NYSE
SCHEDULE: Bank of Montreal Adjusts OPENLANE Stake
Bank of Montreal and its affiliates have updated their beneficial ownership filings for OPENLANE, Inc., reporting a combined stake of 4.52%.
SCHEDULE: Bank of Montreal Adjusts OPENLANE Stake
Bank of Montreal and its affiliates have updated their beneficial ownership filings for OPENLANE, Inc., reporting a combined stake of 4.52%.
NASDAQ
TEAM
Atlassian CORPGQG Partners LLC has reported a beneficial ownership of 4.8% of Atlassian Corporation's Class A Common Stock as of June 30, 2026.
NASDAQ
Blue Owl Capital Holdings LP has disclosed beneficial ownership of 511,177 common shares, representing 0.76% of enGene Therapeutics Inc., acquired via warrants.
NYSE
Bank of Montreal has updated its beneficial ownership filing for North American Construction Group Ltd., reporting a 5.05% stake as of June 30, 2026.
NYSE
Bank of Montreal has updated its beneficial ownership filing for North American Construction Group Ltd., reporting a 5.05% stake as of June 30, 2026.
NASDAQ
Jane Street Group, LLC and its affiliates have reported a significant beneficial ownership stake in Bitdeer Technologies Group, holding 5.7% of the Class A ordinary shares.
NYSE
A group of entities affiliated with Morgan Stanley has reported beneficial ownership of 5,500,000 shares, representing 6.7% of the common stock of NN Inc.
NASDAQ
NNBR
Nn INCA group of entities affiliated with Morgan Stanley has reported beneficial ownership of 5,500,000 shares, representing 6.7% of the common stock of NN Inc.
NASDAQ
AXTI
Axt INCJane Street Group, LLC and its affiliates have filed an amended Schedule 13G, reporting a combined beneficial ownership of 6.7% in AXT Inc. common stock as of June 30, 2026.
NYSE
The Toronto-Dominion Bank and TD Securities Inc. have filed a Schedule 13G, reporting beneficial ownership of 6.9% of UroGen Pharma Ltd.'s ordinary shares.
NASDAQ
The Toronto-Dominion Bank and TD Securities Inc. have filed a Schedule 13G, reporting beneficial ownership of 6.9% of UroGen Pharma Ltd.'s ordinary shares.